These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 19832933
1. Effects of 12-month tadalafil therapy for erectile dysfunction on couple relationships: results from the DETECT study. Verheyden B, Roumeguère T, Bitton A, Belger M, Schmitt H, DETECT study investigators. J Sex Med; 2009 Dec; 6(12):3458-68. PubMed ID: 19832933 [Abstract] [Full Text] [Related]
2. Evaluation of patient expectations and treatment satisfaction after 1-year tadalafil therapy for erectile dysfunction: the DETECT study. Perimenis P, Roumeguere T, Heidler H, Roos E, Belger M, Schmitt H. J Sex Med; 2009 Jan; 6(1):257-67. PubMed ID: 19170854 [Abstract] [Full Text] [Related]
3. Therapeutic response after first month of tadalafil treatment predicts 12 months treatment continuation in patients with erectile dysfunction: results from the DETECT study. Roumeguère T, Verheyden B, Arver S, Bitton A, Belger M, Schmitt H, DETECT study investigators. J Sex Med; 2008 Jul; 5(7):1708-19. PubMed ID: 18331259 [Abstract] [Full Text] [Related]
4. Efficacy and safety of medium and long-term tadalafil use in spinal cord patients with erectile dysfunction. Lombardi G, Macchiarella A, Cecconi F, Del Popolo G. J Sex Med; 2009 Feb; 6(2):535-43. PubMed ID: 19138363 [Abstract] [Full Text] [Related]
5. Sensitivity of the psychological and interpersonal relationship scales to oral therapies for erectile dysfunction. Rosen R, Broderick G, Shabsigh R, Swindle R, Lockhart D, Cameron A. J Sex Med; 2005 Jul; 2(4):461-8. PubMed ID: 16422840 [Abstract] [Full Text] [Related]
6. Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian 'Treatment of Erectile Dysfunction' observational study. Lee J, Pommerville P, Brock G, Gagnon R, Mehta P, Krisdaphongs M, Chan M, Chan J, Dickson R. BJU Int; 2006 Sep; 98(3):623-9. PubMed ID: 16925764 [Abstract] [Full Text] [Related]
7. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers. Carson C, Shabsigh R, Segal S, Murphy A, Fredlund P, Kuepfer C, Trial Evaluating the Activity of Tadalafil for Erectile Dysfunction-United States (TREATED-US) Study Group. Urology; 2005 Feb; 65(2):353-9. PubMed ID: 15708052 [Abstract] [Full Text] [Related]
8. The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners. Brock G, Chan J, Carrier S, Chan M, Salgado L, Klein AH, Lang C, Horner R, Gutkin S, Dickson R. BJU Int; 2007 Feb; 99(2):376-82. PubMed ID: 17155989 [Abstract] [Full Text] [Related]
9. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study. Eardley I, Montorsi F, Jackson G, Mirone V, Chan ML, Loughney K, Vail GM, Beardsworth A. BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960 [Abstract] [Full Text] [Related]
10. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study. Hatzichristou D, Haro JM, Martin-Morales A, von Keitz A, Riley A, Bertsch J, Belger M, Wolka AM, Beardsworth A, EDOS Group. Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306 [Abstract] [Full Text] [Related]
11. Investigating women's preference for sildenafil or tadalafil use by their partners with erectile dysfunction: the partners' preference study. Conaglen HM, Conaglen JV. J Sex Med; 2008 May; 5(5):1198-1207. PubMed ID: 18312284 [Abstract] [Full Text] [Related]
12. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS). Martin-Morales A, Haro JM, Beardsworth A, Bertsch J, Kontodimas S, EDOS Group. Eur Urol; 2007 Feb; 51(2):541-50; discussion 550. PubMed ID: 17084518 [Abstract] [Full Text] [Related]
13. The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress: a multicentre, non-randomised, open-label clinical study. Fugl-Meyer KS, Stothard D, Belger M, Toll A, Berglund O, Eliasson T, Fugl-Meyer AR. Int J Clin Pract; 2006 Nov; 60(11):1386-93. PubMed ID: 17073836 [Abstract] [Full Text] [Related]
14. Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil. McMahon C. J Sex Med; 2004 Nov; 1(3):292-300. PubMed ID: 16422959 [Abstract] [Full Text] [Related]
15. Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report. Liguori G, Trombetta C, De Giorgi G, Pomara G, Maio G, Vecchio D, Ocello G, Ollandini G, Bucci S, Belgrano E. J Sex Med; 2009 Feb; 6(2):544-52. PubMed ID: 19138360 [Abstract] [Full Text] [Related]
17. Efficacy and safety of tadalafil in the treatment of Latin American men with erectile dysfunction: results of integrated analyses. Rubio-Aurioles E, Casabé A, Torres LO, Quinzaños L, Glina S, Filimon I, Kopernicky V, Leñero E. J Sex Med; 2008 Aug; 5(8):1965-76. PubMed ID: 18466266 [Abstract] [Full Text] [Related]
18. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction. Rubio-Aurioles E, Porst H, Kim ED, Montorsi F, Hackett G, Morales AM, Stuckey B, Būttner H, West TM, Huynh NN, Lenero E, Burns P, Kopernicky V. J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760 [Abstract] [Full Text] [Related]